79 related articles for article (PubMed ID: 29760835)
1. Cutaneous Mucormycosis Following a Bullous Pemphigoid Flare in a Chronic Lymphocytic Leukemia Patient on Ibrutinib.
Stein MK; Karri S; Reynolds J; Owsley J; Wise A; Martin MG; Zare F
World J Oncol; 2018 Apr; 9(2):62-65. PubMed ID: 29760835
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous mucormycosis in a chronic lymphocytic leukemia patient on ibrutinib.
Sittig KR; Laageide LG; Akhtar Z; Wall GC; Kumar SC
IDCases; 2021; 24():e01120. PubMed ID: 33912391
[TBL] [Abstract][Full Text] [Related]
3. A case report of the metagenomics next-generation sequencing for early detection of central nervous system mucormycosis with successful rescue in patient with recurrent chronic lymphocytic leukemia.
Zhang J; Luo J; Weng X; Zhu Y; Goyal G; Perna F; Espinoza-Gutarra M; Jiang L; Chen L; Mi JQ
Ann Transl Med; 2022 Jun; 10(12):722. PubMed ID: 35845522
[TBL] [Abstract][Full Text] [Related]
4. Multi-fungal sepsis and mucormycosis of the central nervous system in a patient treated with ibrutinib, a case report and review of the literature.
Fehr M; Cathomas G; Graber A; Makert E; Gaus E; Boggian K
Med Mycol Case Rep; 2020 Mar; 27():14-16. PubMed ID: 31890489
[TBL] [Abstract][Full Text] [Related]
5. Ibrutinib-associated cutaneous mucormycosis due to an
Nguyen TM; Amenta E; Chapman L; Yellapragada S; Krishnan B; Lim J; Hamill RJ
Ther Adv Infect Dis; 2024; 11():20499361241241199. PubMed ID: 38545450
[TBL] [Abstract][Full Text] [Related]
6. Amebic Encephalitis in a Patient with Chronic Lymphocytic Leukemia on Ibrutinib Therapy.
Voshtina E; Huang H; Raj R; Atallah E
Case Rep Hematol; 2018; 2018():6514604. PubMed ID: 30155323
[TBL] [Abstract][Full Text] [Related]
7. Ibrutinib and tracheal mucormycosis: A case report and systematic review of literature.
Damaraju V; Agarwal R; Singh Sehgal I; Khadwal A; Bal A; Rudramurthy SM; Muthu V
J Mycol Med; 2023 Aug; 33(3):101414. PubMed ID: 37523991
[TBL] [Abstract][Full Text] [Related]
8. Cerebral aspergillosis and facial acneiform lesions following initiation of ibrutinib in a patient with chronic lymphocytic leukemia.
Bedier H; Lin J; Frenette C; Routy JP
IDCases; 2021; 26():e01263. PubMed ID: 34504767
[TBL] [Abstract][Full Text] [Related]
9. Fungal Infections with Ibrutinib and Other Small-Molecule Kinase Inhibitors.
Zarakas MA; Desai JV; Chamilos G; Lionakis MS
Curr Fungal Infect Rep; 2019 Sep; 13(3):86-98. PubMed ID: 31555394
[TBL] [Abstract][Full Text] [Related]
10. Insect Bite-Like Reaction with Bullous Lesions Mimicking Bullous Pemphigoid in a Patient with Chronic Lymphocytic Leukemia.
Kim JE; Kim SC
Ann Dermatol; 2018 Aug; 30(4):468-472. PubMed ID: 30065590
[TBL] [Abstract][Full Text] [Related]
11. A Rare Instance of Simultaneous Infection with Disseminated Nocardia and Pulmonary Aspergillus in a Patient Receiving Treatment with Ibrutinib for Chronic Lymphocytic Leukemia.
Dotson J; Katz H; Jafri H; Jamil MO; Willenburg KS
Cureus; 2018 Oct; 10(10):e3427. PubMed ID: 30542637
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic and pharmacodynamic evaluation of ibrutinib for the treatment of chronic lymphocytic leukemia: rationale for lower doses.
Bose P; Gandhi VV; Keating MJ
Expert Opin Drug Metab Toxicol; 2016 Nov; 12(11):1381-1392. PubMed ID: 27686109
[TBL] [Abstract][Full Text] [Related]
13. Infections in patients with chronic lymphocytic leukaemia: Mitigating risk in the era of targeted therapies.
Teh BW; Tam CS; Handunnetti S; Worth LJ; Slavin MA
Blood Rev; 2018 Nov; 32(6):499-507. PubMed ID: 29709246
[TBL] [Abstract][Full Text] [Related]
14. Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Barrientos JC; O'Brien S; Brown JR; Kay NE; Reddy NM; Coutre S; Tam C; Mulligan S; Jaeger U; Devereux S; Pocock C; Robak T; Schuster SJ; Schuh A; Gill D; Bloor A; Dearden C; Moreno C; Cull G; Hamblin M; Jones JA; Eckert K; Solman IG; Suzuki S; Hsu E; James DF; Byrd JC; Hillmen P
Clin Lymphoma Myeloma Leuk; 2018 Dec; 18(12):803-813.e7. PubMed ID: 30249389
[TBL] [Abstract][Full Text] [Related]
15. Cost of Illness of Japanese Patients with Chronic Lymphocytic Leukemia (CLL), and Budget Impact of the Market Introduction of Ibrutinib.
Mahlich J; Okamoto S; Tsubota A
Pharmacoecon Open; 2017 Sep; 1(3):195-202. PubMed ID: 29441498
[TBL] [Abstract][Full Text] [Related]
16. Successful posaconazole salvage therapy for rhinocerebral mucormycosis in a child with leukemia. Review of the literature.
Ojeda-Diezbarroso K; Aguilar-Rascón J; Jiménez-Juárez RN; Moreno-Espinosa S; Reséndiz-Sánchez J; Romero-Zamora JL
Rev Iberoam Micol; 2019; 36(3):160-164. PubMed ID: 31563327
[TBL] [Abstract][Full Text] [Related]
17. Treatment Outcomes of Novel Targeted Agents in Relapse/Refractory Chronic Lymphocytic Leukemia: A Systematic Review and Network Meta-Analysis.
Chen PH; Ho CL; Lin C; Wu YY; Huang TC; Tu YK; Lee CH
J Clin Med; 2019 May; 8(5):. PubMed ID: 31126075
[TBL] [Abstract][Full Text] [Related]
18. Invasive aspergillosis related to ibrutinib therapy for chronic lymphocytic leukemia.
Arthurs B; Wunderle K; Hsu M; Kim S
Respir Med Case Rep; 2017; 21():27-29. PubMed ID: 28377877
[TBL] [Abstract][Full Text] [Related]
19. Current Treatment of Chronic Lymphocytic Leukemia.
Jamroziak K; Puła B; Walewski J
Curr Treat Options Oncol; 2017 Jan; 18(1):5. PubMed ID: 28185174
[TBL] [Abstract][Full Text] [Related]
20. Ibrutinib-Associated Nail Plate Abnormalities: Case Reports and Review.
Heldt Manica LA; Cohen PR
Drug Saf Case Rep; 2017 Nov; 4(1):15. PubMed ID: 29094220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
